Published in Nature on August 15, 1991
Methods for high-density admixture mapping of disease genes. Am J Hum Genet (2004) 12.02
Evolutionary and historical aspects of the burden of malaria. Clin Microbiol Rev (2002) 6.07
How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet (2005) 5.79
Relation between falciparum malaria and bacteraemia in Kenyan children: a population-based, case-control study and a longitudinal study. Lancet (2011) 3.78
Decomposing health: tolerance and resistance to parasites in animals. Philos Trans R Soc Lond B Biol Sci (2009) 3.40
A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci U S A (1994) 3.33
CISH and susceptibility to infectious diseases. N Engl J Med (2010) 3.31
Plasmodium falciparum erythrocyte invasion through glycophorin C and selection for Gerbich negativity in human populations. Nat Med (2002) 3.29
Sickle cell trait and the risk of Plasmodium falciparum malaria and other childhood diseases. J Infect Dis (2005) 3.12
X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria. PLoS Med (2007) 2.94
A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms. Am J Hum Genet (2005) 2.85
Genetic analysis of completely sequenced disease-associated MHC haplotypes identifies shuffling of segments in recent human history. PLoS Genet (2006) 2.80
The importance of immune gene variability (MHC) in evolutionary ecology and conservation. Front Zool (2005) 2.80
Sickle cell trait is associated with a delayed onset of malaria: implications for time-to-event analysis in clinical studies of malaria. J Infect Dis (2008) 2.77
Bacterial antigenic variation, host immune response, and pathogen-host coevolution. Infect Immun (1993) 2.68
Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara. Proc Natl Acad Sci U S A (2005) 2.57
Haemoglobinopathies and the clinical epidemiology of malaria: a systematic review and meta-analysis. Lancet Infect Dis (2012) 2.49
MHC heterozygosity confers a selective advantage against multiple-strain infections. Proc Natl Acad Sci U S A (2002) 2.45
Genetic susceptibility to tuberculosis in Africans: a genome-wide scan. Proc Natl Acad Sci U S A (2000) 2.44
Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines. J Exp Med (2002) 2.38
HLA and infectious diseases. Clin Microbiol Rev (2009) 2.35
Polymorphism and balancing selection at major histocompatibility complex loci. Genetics (1992) 2.34
A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya. PLoS Clin Trials (2006) 2.33
Different response to Plasmodium falciparum malaria in west African sympatric ethnic groups. Proc Natl Acad Sci U S A (1996) 2.25
Impaired cytoadherence of Plasmodium falciparum-infected erythrocytes containing sickle hemoglobin. Proc Natl Acad Sci U S A (2008) 2.19
Major histocompatibility complex variation associated with juvenile survival and parasite resistance in a large unmanaged ungulate population. Proc Natl Acad Sci U S A (1998) 2.13
An immune basis for malaria protection by the sickle cell trait. PLoS Med (2005) 2.08
Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. Proc Natl Acad Sci U S A (2007) 2.07
The evolution and maintenance of virulence in microparasites. Emerg Infect Dis (1996) 2.07
Genotyping of Plasmodium falciparum isolates by the polymerase chain reaction and potential uses in epidemiological studies. Bull World Health Organ (1995) 2.00
The contribution of Plasmodium chabaudi to our understanding of malaria. Trends Parasitol (2011) 1.99
Current status of malaria and potential for control. Clin Microbiol Rev (2001) 1.92
Population genetics of malaria resistance in humans. Heredity (Edinb) (2011) 1.85
Malaria in humans: Plasmodium falciparum blood infection levels are linked to chromosome 5q31-q33. Am J Hum Genet (1998) 1.78
Malaria as a cause of morbidity and mortality in children with homozygous sickle cell disease on the coast of Kenya. Clin Infect Dis (2009) 1.74
Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment. J Clin Invest (2001) 1.72
Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data. Malar J (2009) 1.72
A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition. J Exp Med (2003) 1.72
Hemoglobin S and C heterozygosity enhances neither the magnitude nor breadth of antibody responses to a diverse array of Plasmodium falciparum antigens. J Infect Dis (2011) 1.71
A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults. PLoS Med (2004) 1.70
Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa. Clin Vaccine Immunol (2009) 1.67
Association between major histocompatibility complex class IIB alleles and resistance to Aeromonas salmonicida in Atlantic salmon. Proc Biol Sci (2001) 1.64
Rapid definition of five novel HLA-A*3002-restricted human immunodeficiency virus-specific cytotoxic T-lymphocyte epitopes by elispot and intracellular cytokine staining assays. J Virol (2001) 1.63
MHC polymorphism under host-pathogen coevolution. Immunogenetics (2004) 1.61
Intensity of natural selection at the major histocompatibility complex loci. Proc Natl Acad Sci U S A (1994) 1.59
Parasite virulence and disease patterns in Plasmodium falciparum malaria. Proc Natl Acad Sci U S A (1994) 1.57
Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics. Hum Genet (2008) 1.57
A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol (1998) 1.56
Major histocompatibility complex heterozygote superiority during coinfection. Infect Immun (2003) 1.52
HLA antigens in Omanis with blinding trachoma: markers for disease susceptibility and resistance. Br J Ophthalmol (1997) 1.45
IgE elevation and IgE anti-malarial antibodies in Plasmodium falciparum malaria: association of high IgE levels with cerebral malaria. Clin Exp Immunol (1994) 1.44
Leprosy and the adaptation of human toll-like receptor 1. PLoS Pathog (2010) 1.41
Sickle cell disease in Africa: burden and research priorities. Ann Trop Med Parasitol (2007) 1.41
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology (2008) 1.40
Rapid evolution of major histocompatibility complex class I genes in primates generates new disease alleles in humans via hitchhiking diversity. Genetics (2006) 1.37
Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody- and T cell-mediated multistage protection against malaria. Cell Host Microbe (2009) 1.36
Interethnic genetic differentiation in Africa: HLA class I antigens in The Gambia. Am J Hum Genet (1992) 1.35
A hypothesis for the HLA-B27 immune dysregulation in spondyloarthropathy: contributions from enteric organisms, B27 structure, peptides bound by B27, and convergent evolution. Proc Natl Acad Sci U S A (1993) 1.34
A novel single cDNA amplicon pyrosequencing method for high-throughput, cost-effective sequence-based HLA class I genotyping. Hum Immunol (2010) 1.33
Shape and Biomechanical Characteristics of Human Red Blood Cells in Health and Disease. MRS Bull (2010) 1.31
Molecular genetics of speciation and human origins. Proc Natl Acad Sci U S A (1994) 1.31
Meta-analysis of immune epitope data for all Plasmodia: overview and applications for malarial immunobiology and vaccine-related issues. Parasite Immunol (2009) 1.30
Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum circumsporozoite protein. Infect Immun (2006) 1.30
Genetic polymorphisms linked to susceptibility to malaria. Malar J (2011) 1.29
HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses. J Virol (2010) 1.29
Associations between malaria and MHC genes in a migratory songbird. Proc Biol Sci (2005) 1.29
Major histocompatibility complex (MHC) heterozygote superiority to natural multi-parasite infections in the water vole (Arvicola terrestris). Proc Biol Sci (2009) 1.27
Quantifying genetic and nongenetic contributions to malarial infection in a Sri Lankan population. Proc Natl Acad Sci U S A (2000) 1.27
Experimental evidence for major histocompatibility complex-allele-specific resistance to a bacterial infection. Proc Biol Sci (2002) 1.26
Maintenance of MHC polymorphism. Nature (1992) 1.25
Lifetime reproductive success is maximized with optimal major histocompatibility complex diversity. Proc Biol Sci (2009) 1.24
A role for fetal hemoglobin and maternal immune IgG in infant resistance to Plasmodium falciparum malaria. PLoS One (2011) 1.24
HLA-DR polymorphism in a Senegalese Mandenka population: DNA oligotyping and population genetics of DRB1 specificities. Am J Hum Genet (1992) 1.22
Heterozygote advantage fails to explain the high degree of polymorphism of the MHC. Immunogenetics (2004) 1.22
Characterization of peripheral blood lymphocyte subsets in patients with acute Plasmodium falciparum and P. vivax malaria infections at Wonji Sugar Estate, Ethiopia. Clin Vaccine Immunol (2006) 1.22
Cloned lines of Plasmodium berghei ANKA differ in their abilities to induce experimental cerebral malaria. Infect Immun (1998) 1.22
Genetic variation in human HBB is associated with Plasmodium falciparum transmission. Nat Genet (2010) 1.21
Heritable variation in resistance to gastro-intestinal nematodes in an unmanaged mammal population. Proc Biol Sci (1999) 1.20
Extensive genetic diversity in the HLA class II region of Africans, with a focally predominant allele, DRB1*1304. Proc Natl Acad Sci U S A (1992) 1.20
Does intra-individual major histocompatibility complex diversity keep a golden mean? Philos Trans R Soc Lond B Biol Sci (2009) 1.20
Evidence for directional selection at a novel major histocompatibility class I marker in wild common frogs (Rana temporaria) exposed to a viral pathogen (Ranavirus). PLoS One (2009) 1.19
A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses. Proc Natl Acad Sci U S A (2003) 1.18
The impact of multiple infections on wild animal hosts: a review. Infect Ecol Epidemiol (2011) 1.17
Severe malaria in Gambian children is not due to lack of previous exposure to malaria. Clin Exp Immunol (1992) 1.17
Classical sickle beta-globin haplotypes exhibit a high degree of long-range haplotype similarity in African and Afro-Caribbean populations. BMC Genet (2007) 1.16
Impact of malaria on genetic polymorphism and genetic diseases in Africans and African Americans. Proc Natl Acad Sci U S A (1994) 1.16
Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain. Proc Natl Acad Sci U S A (1995) 1.15
HLA-A2 subtypes are functionally distinct in peptide binding and presentation. J Exp Med (1995) 1.14
Evidence for both innate and acquired mechanisms of protection from Plasmodium falciparum in children with sickle cell trait. Blood (2012) 1.13
Discordant patterns of linkage disequilibrium of the peptide-transporter loci within the HLA class II region. Am J Hum Genet (1995) 1.13
Immunology. Disease and evolution. Nature (1991) 1.13
Plasmodium relictum infection and MHC diversity in the house sparrow (Passer domesticus). Proc Biol Sci (2010) 1.12
Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3. Infect Immun (2000) 1.12
HLA polymorphism in the Havasupai: evidence for balancing selection. Am J Hum Genet (1993) 1.12
Diversity of Mhc class I and IIB genes in house sparrows (Passer domesticus). Immunogenetics (2004) 1.12
Genetic regulation of human anti-malarial antibodies in twins. Proc Natl Acad Sci U S A (1992) 1.11
MHC standing genetic variation and pathogen resistance in wild Atlantic salmon. Philos Trans R Soc Lond B Biol Sci (2009) 1.11
Process development and analysis of liver-stage antigen 1, a preerythrocyte-stage protein-based vaccine for Plasmodium falciparum. Infect Immun (2005) 1.10
KIR haplotypes defined by segregation analysis in 59 Centre d'Etude Polymorphisme Humain (CEPH) families. Immunogenetics (2008) 1.10
Phenotypic analysis of antigen-specific T lymphocytes. Science (1996) 24.26
The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell (1986) 14.96
Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med (1997) 12.26
Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science (1998) 12.05
Simple sample size calculation for cluster-randomized trials. Int J Epidemiol (1999) 10.46
Averting a malaria disaster. Lancet (1999) 9.40
Mortality and morbidity from malaria in Gambian children after introduction of an impregnated bednet programme. Lancet (1995) 8.71
Cytotoxic T-cell immunity to influenza. N Engl J Med (1983) 8.49
Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature (2001) 7.90
Bias due to misclassification in the estimation of relative risk. Am J Epidemiol (1977) 7.28
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature (1998) 7.12
Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med (2001) 6.51
Standardized mortality ratios and the "healthy worker effect": Scratching beneath the surface. J Occup Med (1976) 6.40
Rapid effector function in CD8+ memory T cells. J Exp Med (1997) 6.36
TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet (1990) 6.32
Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature. Clin Infect Dis (2000) 6.06
Counter-current immunoelectrophoresis in the diagnosis of meningococcal infections. Lancet (1971) 6.05
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med (2000) 5.79
Environmental exposure to lead and children's intelligence at the age of seven years. The Port Pirie Cohort Study. N Engl J Med (1992) 5.49
HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature (1988) 5.45
Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo. J Exp Med (1998) 5.33
A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody. Eur J Immunol (1979) 5.17
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet (2001) 5.01
Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Lancet (2007) 4.85
Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection. Trans R Soc Trop Med Hyg (1990) 4.70
Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet (1990) 4.58
Potential impact of global climate change on malaria risk. Environ Health Perspect (1995) 4.44
Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature (1995) 4.42
Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature (1994) 4.37
Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet (1995) 4.34
Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells. Cell (1984) 3.97
Large clonal expansions of CD8+ T cells in acute infectious mononucleosis. Nat Med (1996) 3.94
Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature (1992) 3.93
Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J Virol (1999) 3.79
Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma. EMBO J (1988) 3.77
Analysis of survival data by the proportional odds model. Stat Med (1984) 3.70
Excess mortality in England and Wales, and in Greater London, during the 1995 heatwave. J Epidemiol Community Health (1998) 3.67
Rapid bacteriological diagnosis of pyogenic meningitis by latex agglutination. Lancet (1974) 3.64
Overlap in the clinical features of pneumonia and malaria in African children. Trans R Soc Trop Med Hyg (1994) 3.58
Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med (1995) 3.54
Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J Clin Invest (1998) 3.53
Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J Infect Dis (1996) 3.49
Association of malaria parasite population structure, HLA, and immunological antagonism. Science (1998) 3.40
Respiratory syncytial virus infection in tropical and developing countries. Trop Med Int Health (1998) 3.38
A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. J Immunol (1999) 3.36
A trial of artemether or quinine in children with cerebral malaria. N Engl J Med (1996) 3.28
Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria. Clin Infect Dis (2007) 3.27
Cancer prevalence in the United Kingdom: estimates for 2008. Br J Cancer (2009) 3.27
Poisoning by bites of the saw-scaled or carpet viper (Echis carinatus) in Nigeria. Q J Med (1977) 3.27
Autoimmune disease and parasitic infections in Nigerians. Lancet (1968) 3.22
Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science (2000) 3.20
Efficacy trial of malaria vaccine SPf66 in Gambian infants. Lancet (1995) 3.20
Meiotic pachytene arrest in MLH1-deficient mice. Cell (1996) 3.18
The epidemiology of melioidosis in Australia and Papua New Guinea. Acta Trop (2000) 3.16
Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol (1992) 3.12
High incidence of malaria in alpha-thalassaemic children. Nature (1996) 3.12
Crop management and agronomic context of the Farm Scale Evaluations of genetically modified herbicide-tolerant crops. Philos Trans R Soc Lond B Biol Sci (2003) 3.12
Immunosuppression in children with malaria. Lancet (1972) 3.11
Neurological sequelae of cerebral malaria in children. Lancet (1990) 3.11
Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia. Trans R Soc Trop Med Hyg (2006) 3.08
A human lymphocyte-associated antigen involved in cell-mediated lympholysis. Eur J Immunol (1983) 3.08
A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses. Nat Med (2000) 3.06
Field evaluation of the ICT malaria P.f/P.v immunochromatographic test for detection of Plasmodium falciparum and Plasmodium vivax in patients with a presumptive clinical diagnosis of malaria in eastern Indonesia. J Clin Microbiol (1999) 3.05
High recombination rate in natural populations of Plasmodium falciparum. Proc Natl Acad Sci U S A (1999) 3.03
Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection. AIDS Res Hum Retroviruses (1996) 3.01
Evaluation of an algorithm for the integrated management of childhood illness in an area with seasonal malaria in the Gambia. Bull World Health Organ (1997) 3.00
Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med (1978) 3.00
Investigation of the risk factors for tuberculosis: a case-control study in three countries in West Africa. Int J Epidemiol (2005) 2.97
Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guérin vaccination. J Immunol (1999) 2.94
Ecological study of reasons for sharp decline in mortality from ischaemic heart disease in Poland since 1991. BMJ (1998) 2.94
Mena is required for neurulation and commissure formation. Neuron (1999) 2.94
Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. Proc Natl Acad Sci U S A (1991) 2.90
HLA restriction of cell-mediated lysis of influenza virus-infected human cells. Nature (1977) 2.88
A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet (1999) 2.83
Possible role of a B-cell mitogen in hypergammaglobulinaemia in malaria and trypanosomiasis. Lancet (1974) 2.83
Cytotoxic T-cell recognition of HIV proteins and peptides. AIDS (1991) 2.83
Determinants of in vitro drug susceptibility testing of Plasmodium vivax. Antimicrob Agents Chemother (2008) 2.77
Pneumococcal antigen in lobar pneumonia. J Clin Pathol (1975) 2.75
A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals. AIDS (1999) 2.75
The etiology of pneumonia in malnourished and well-nourished Gambian children. Pediatr Infect Dis J (1994) 2.73
Melioidosis: acute and chronic disease, relapse and re-activation. Trans R Soc Trop Med Hyg (2000) 2.71
High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals. Int Immunol (1990) 2.71
Early effects of climate change: do they include changes in vector-borne disease? Philos Trans R Soc Lond B Biol Sci (2001) 2.71